Trial site
Nantes
- 14running trials
- 8closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia5 trials
- Coronary artery disease5 trials
- Familial hypercholesterolaemia3 trials
- Stroke3 trials
- Hidradenitis suppurativa2 trials
- Multiple sclerosis2 trials
- Aortic stenosis1 trial
- Colorectal cancer1 trial
- Heart failure1 trial
- IgA nephropathy1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- and 2 more
- Phase
- Phase 313 trials
- Phase 23 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed7 trials
- Recruiting6 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals22 trials
Running trials
Recruiting
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
- Multiple sclerosis1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 18 Nov 2026